Cargando…
Multidrug-resistant tuberculosis: diagnosis, checklists, adverse events, advice and outcomes
The account of MDR-TB in Finland describes current practice. Genetic testing of primary specimens, whole-genome sequencing, supportive directly observed therapy, checklists and national consilia will contribute to further improvements in managing MDR-TB. https://bit.ly/3rOnb3u
Autor principal: | Bothamley, Graham H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Respiratory Society
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9703147/ https://www.ncbi.nlm.nih.gov/pubmed/36451839 http://dx.doi.org/10.1183/23120541.00512-2022 |
Ejemplares similares
-
Rapid diagnosis and shorter regimen for multidrug-resistant tuberculosis: A priority to improve treatment outcome
por: Prasad, Rajendra, et al.
Publicado: (2017) -
Linezolid-Associated Neurologic Adverse Events in Patients with Multidrug-Resistant Tuberculosis, France
por: Jaspard, Marie, et al.
Publicado: (2020) -
Fluoroquinolone resistance in multidrug-resistant tuberculosis patients
por: Lee, Hyun-Woo, et al.
Publicado: (2019) -
Adverse Events Associated with Treatment of Multidrug-Resistant Tuberculosis in China: An Ambispective Cohort Study
por: Zhang, Yang, et al.
Publicado: (2017) -
The Tuberculosis Network European Trials Group (TBNET): new directions in the management of tuberculosis
por: Bothamley, Graham
Publicado: (2017)